# 体外二氧化碳去除设备市场

> 体外二氧化碳去除装置市场规模、增长研究报告，按技术（膜技术、吸收技术、低温技术、吸附技术）、按应用（医院使用、居家护理、紧急医疗服务、运输）、按设备类型（便携式设备、固定设备、一次性设备）、按最终用途（临床环境、研究机构、居家医疗）以及按地区（北美、欧洲、南美、亚太、中东和非洲）- 竞争对手行业分析和趋势预测至2035年

- **Forecast Period:** 2025 - 2035
- **CAGR:** 10.29%
- **2024:** $ 1.26 Billion
- **2025:** $ 1.39 Billion
- **2035:** $ 3.7 Billion
- **Key Players:** Medtronic (US), Fresenius Medical Care (DE), Baxter International (US), Getinge (SE), LivaNova (GB), Asahi Kasei Medical (JP), Nipro Corporation (JP), Terumo Corporation (JP)

**Report ID:** MRFR/HC/35344-HCR · **Pages:** 128 · **Author:** Satyendra Maurya & Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/extracorporeal-co2-removal-device-market-37282

---

## Market Summary

## **Extracorporeal CO2 Removal Device Market Overview**

As per MRFR analysis, the Extracorporeal Co2 Removal Device Market Size was estimated at 1.26 (USD Billion) in 2024. The Extracorporeal Co2 Removal Device Market Industry is expected to grow from 1.39 (USD Billion) in 2025 to 3.36 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 10.29% during the forecast period (2025 - 2034).

### **Key Extracorporeal CO2 Removal Device Market Trends Highlighted**

The Extracorporeal CO2 Removal Device Market is witnessing significant growth driven by an increased prevalence of respiratory disorders and the rising aging population. These devices offer a vital solution for patients with severe lung conditions, providing effective gas exchange and improving oxygenation levels. Additionally, advancements in medical technology, coupled with heightened awareness about respiratory therapies, are pushing healthcare facilities to incorporate these devices into their treatment protocols. The emphasis on improving patient outcomes is a strong motivating factor for hospitals and clinics to invest in advanced CO2 removal systems.

There are numerous opportunities within this market that can be explored. The growing demand for non-invasive respiratory support solutions presents avenues for manufacturers to innovate and develop advanced products that meet diverse patient needs. Moreover, there is potential for growth in emerging markets where healthcare infrastructure is rapidly developing. Collaborations between medical device manufacturers and healthcare providers can lead to tailored solutions that enhance treatment capabilities. Developing countries are focusing on improving their healthcare systems, which opens doors for companies to introduce their CO2 removal technologies and expand their market presence.

In recent times, there has been a notable trend toward integrating digital health technologies with extracorporeal CO2 removal devices. Innovations such as remote monitoring and real-time data analytics are becoming integral to patient management, leading to better monitoring of treatment efficacy. The trend toward personalized medicine is also influencing the development of these devices, allowing for tailored therapies based on individual patient needs. Regulatory bodies are increasingly supporting advancements in technology, easing the pathways for new products to enter the market. Overall, this market is set to evolve with continuous advancements and a greater focus on patient-centred care.

## 

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Extracorporeal CO2 Removal Device Market Drivers**

#### **Increasing Prevalence of Respiratory Disorders**

The growing incidence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and other lung-related ailments significantly drives the Extracorporeal CO2 Removal Device Market Industry. As more individuals are diagnosed with these conditions, the demand for effective treatment solutions expands. Extracorporeal CO2 removal devices are being increasingly recognized as vital tools for managing respiratory retention of carbon dioxide.

These devices allow for the removal of CO2 from patients' blood, thus enhancing the efficacy of traditional therapies and providing a life-saving option for critically ill patients experiencing severe respiratory failure. The need for better management tools motivates healthcare institutions to invest in advanced technologies that can provide real-time interventions. Furthermore, advancements in these devices to improve their efficiency and patient outcomes directly correlate with the rise in adoption rates.

As hospitals and healthcare providers focus on improving the quality of care and outcomes for patients with severe respiratory conditions, the demand for extracorporeal CO2 removal devices is anticipated to increase, marking a positive outlook for the Extracorporeal CO2 Removal Device Market.

#### **Technological Advancements in Medical Devices**

Technological advancements in medical devices play a crucial role in propelling the Extracorporeal CO2 Removal Device Market Industry. Innovations yield products that are more efficient, user-friendly, and capable of integrating with existing medical systems. Enhanced functionality, such as automated monitoring and improved filters, increases the effectiveness of these devices, leading to better patient outcomes. Moreover, the incorporation of artificial intelligence and machine learning in these devices enables personalized treatments for patients, catering to their specific needs.

As companies continue to invest in R to bring novel features to the forefront, the market is likely to witness an upsurge in demand.

#### **Rising Geriatric Population**

The rapid growth of the geriatric population worldwide fosters the expansion of the Extracorporeal CO2 Removal Device Market Industry. Older adults are more susceptible to respiratory diseases due to various factors such as decreased lung function and pre-existing health conditions. Consequently, healthcare systems must adapt, ensuring the availability of effective treatment options tailored for this demographic. The increasing healthcare expenditure directed towards supporting the aging population drives investments in new medical technologies, including extracorporeal CO2 removal devices, thereby enhancing market growth.

## **Extracorporeal CO2 Removal Device Market Segment Insights**

### **Extracorporeal CO2 Removal Device Market Technology Insights**

The Extracorporeal CO2 Removal Device Market, focusing on the Technology segment, has shown considerable prospects for growth and innovation. In 2023, the market was valued at 1.04 USD Billion, with a positive outlook toward its growth trajectory. Among the various technologies driving this market, [Membrane Technology](../../../reports/membrane-technology-market-29973) holds a majority with a valuation of 0.38 USD Billion, which is anticipated to expand significantly to 0.95 USD Billion by 2032.

Membrane Technology dominates the landscape due to its efficiency in selectively permeating gases, making it a preferred choice for CO2 removal in clinical settings.Absorption Technology follows as a significant contender, valued at 0.3 USD Billion in 2023, expected to reach 0.75 USD Billion by 2032. This technology's popularity lies in its ability to utilize chemical solvents to capture CO2, making it essential for advanced respiratory support systems.

Cryogenic Technology, valued at 0.2 USD Billion in 2023 and projected to grow to 0.5 USD Billion by 2032, is noteworthy for its innovative approach that leverages low temperatures to separate CO2 effectively, albeit having a smaller share compared to Membrane and Absorption Technologies.

Lastly, Adsorption Technology, with a current valuation of 0.16 USD Billion and an expected increase to 0.4 USD Billion by 2032, utilizes solid adsorbents to capture CO2, highlighting its use in specific applications, although it holds the least dominant position in the market due to its higher operational complexity and costs.

Overall, the diverse methodologies within this segment underscore the Extracorporeal CO2 Removal Device Market's aim to improve respiratory therapies and healthcare outcomes, fostering exciting opportunities for advancements in technology applications and market evolution.The statistics indicate robust opportunities for players within the industry, making it an attractive segment for investment and development moving forward.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Extracorporeal CO2 Removal Device Market Application Insights**

Extracorporeal CO2 Removal Device MarketThe application segment is broadly segmented into hospital use, home care, emergency medical services and transport, each playing a pivotal role in enhancing respiratory support for patients. Hospital use remains a significant contributor due to the high patient turnover and the need for advanced ventilation strategies in critical care environments.Home care is gaining traction as more patients prefer receiving treatment in the comfort of their homes, driven by technological advancements and increased patient awareness.

Emergency medical services are crucial for providing immediate care to patients experiencing respiratory distress, showcasing the necessity of portable extracorporeal devices. Transport applications are vital for maintaining patient stability during transfer, emphasizing the devices' importance in ensuring the safe and efficient movement of patients across different care settings.This diverse application landscape illustrates the growing demand for effective CO2 removal solutions within the Extracorporeal CO2 Removal Device Market, backed by favorable market trends and an expanding patient demographic. The market growth is propelled by technological advancements and improving healthcare infrastructure globally.

### **Extracorporeal CO2 Removal Device Market Device Type Insights**

Extracorporeal CO2 Removal Device MarketThis market is notably segmented into various device types, primarily including Portable Devices, Stationary Devices and Single-Use Devices. Portable Devices are gaining traction due to their flexibility and ease of use, making them ideal for at-home care and emergency applications. Stationary Devices, on the other hand, play a pivotal role in clinical settings, offering high-performance solutions for continuous CO2 removal.

Single-use devices are increasingly favored for their convenience and reduced risk of cross-contamination, addressing patient safety concerns in medical environments. The growth of these device types is driven by factors such as the rising prevalence of respiratory diseases, the increasing demand for portable medical solutions, and advancements in technology that enhance device efficacy. However, the market also faces challenges, such as regulatory hurdles and the need for significant investment in research and development.

The ongoing trend towards less invasive procedures and patient-centered care presents numerous opportunities for further innovation within the Extracorporeal CO2 Removal Device Market, setting a solid foundation for future growth.

### **Extracorporeal CO2 Removal Device Market End Use Insights**

Extracorporeal CO2 Removal Device MarketThe market segmentation reflects various end uses that cater to distinct needs in the healthcare ecosystem. Clinical settings are a major focus, as they require reliable and advanced devices for managing patients who need acute care, thus enhancing the demand in this sector. Research institutions also play a significant role in the market, driving innovations and technological advancements that enhance the functionality of CO2 removal devices.Meanwhile, the growing trend of home healthcare is gaining momentum, offering the convenience of treatment in a home environment, appealing to patients seeking comfort and more manageable recovery processes.

Together, these end-use categories encapsulate the evolving landscape of the Extracorporeal CO2 Removal Device Market, highlighting key areas of opportunity as healthcare continues to innovate and evolve according to patient needs and advanced technologies. The overall market is projected to witness a CAGR of 10.29 from 2024 to 2032, underscoring the importance of these segments within the larger framework of Extracorporeal CO2 Removal Device Market revenue and growth dynamics.

### **Extracorporeal CO2 Removal Device Market Regional Insights**

The Extracorporeal CO2 Removal Device Market revenue demonstrates robust regional diversification, reflecting varying growth dynamics across different geographies. In 2023, North America led the market with a valuation of 0.52 USD Billion and is projected to rise to 1.25 USD Billion by 2032, showcasing its significant role in the industry. Europe follows with a market valuation of 0.3 USD Billion in 2023, expected to reach 0.75 USD Billion, driven by the increasing adoption of advanced respiratory devices.

The APAC region, although smaller, displays promising growth from 0.15 USD Billion to 0.4 USD Billion, highlighting a growing focus on healthcare improvements in emerging economies.

South America and MEA are currently the least dominant regions, with valuations of 0.05 USD Billion and 0.02 USD Billion respectively in 2023; however, they suggest potential for development in their healthcare systems. The market growth in these regions is influenced by increased healthcare expenditures, technological advancements, and a rising prevalence of chronic respiratory diseases, presenting opportunities for market players to capitalize on. The Extracorporeal CO2 Removal Device Market segmentation indicates a clear preference for North America and Europe, while APAC shows promising incremental growth.

## **Extracorporeal CO2 Removal Device Market Key Players and Competitive Insights**

The Extracorporeal CO2 Removal Device Market is undergoing significant transformations driven by advances in technology and an increasing need for effective CO2 management in clinical settings. Companies in this sector are focusing on innovative product development, enhancing existing solutions, and broadening applications in various medical scenarios, particularly in respiratory care. The market features a blend of established players and emerging entrants, each striving to capture market share through strategic partnerships, technological advancements, and customer-centric approaches.

Competitive insights reveal a landscape characterized by rapid innovation, aggressive marketing strategies, and a keen focus on regulatory compliance, all aimed at meeting the diverse needs of healthcare providers and patients.CO2 Solutions has carved out a notable presence in the Extracorporeal CO2 Removal Device Market through its advanced technology aimed at improving patient outcomes and addressing clinical needs.

The company's strengths lie in its proprietary CO2 removal technology, which provides a high degree of efficiency and effectiveness in managing carbon dioxide levels in patients with respiratory conditions. By focusing on research and development, CO2 Solutions has built a robust portfolio of products tailored to the specific demands of the medical community, enhancing its competitive edge.

The emphasis on partnerships with healthcare institutions bolsters its market presence, allowing for greater accessibility and integration of its devices into various medical environments, thereby reinforcing its reputation as a key player in this specialized market.Baxter International is recognized as a significant competitor in the Extracorporeal CO2 Removal Device Market, leveraging its extensive experience and established infrastructure within the healthcare industry.

The company benefits from a broad reach and a diverse range of products that cater to different segments of patient care, which positions it effectively against competitors. Baxter's strengths include its robust distribution network and a commitment to innovation, enabling it to respond swiftly to market changes and customer needs. The focus on high-quality manufacturing and adherence to rigorous regulatory standards further enhances Baxter's credibility and reliability in the eyes of healthcare providers.

As a result, Baxter International continues to expand its influence and footprint within the extracorporeal CO2 removal market, emphasizing its role in delivering effective solutions for patient care across the globe.

### **Key Companies in the Extracorporeal CO2 Removal Device Market Include**

### **Extracorporeal CO2 Removal Device Market Industry Developments**

Recent developments in the Extracorporeal CO2 Removal Device Market highlight a growing emphasis on innovative technologies and strategic collaborations among key players. Companies such as Medtronic and Baxter International have reported advancements in their device functionalities aimed at enhancing patient outcomes. Furthermore, Pulmonx Corporation has seen an increase in market share due to its pioneering lung volume reduction techniques, which integrate CO2 removal devices effectively. In terms of mergers and acquisitions, there have been notable activities, particularly with Getinge AB and Teleflex Incorporated, pursuing strategic alliances to broaden their product portfolios and improve market reach.

This trend of consolidation reflects a competitive landscape focused on integrating advanced technologies to cater to rising global healthcare demands.

Additionally, the market has witnessed a significant uplift in valuation as healthcare providers invest in devices that promise improved patient care and increased operational efficiencies. The overall prognosis for the Extracorporeal CO2 Removal Device Market remains positive, driven by an urgent need for effective respiratory support technologies amid increasing chronic respiratory conditions globally.

## **Extracorporeal CO2 Removal Device Market Segmentation Insights**

### **Extracorporeal CO2 Removal Device Market Technology Outlook**

### **Extracorporeal CO2 Removal Device Market Application Outlook**

### **Extracorporeal CO2 Removal Device Market Device Type Outlook**

### **Extracorporeal CO2 Removal Device Market End Use Outlook**

### **Extracorporeal CO2 Removal Device Market Regional Outlook**

## Market Drivers

### 呼吸系统疾病发病率上升

呼吸系统疾病的流行率正在上升，显著影响体外二氧化碳去除设备市场。慢性阻塞性肺病（COPD）和急性呼吸窘迫综合症（ARDS）等疾病变得越来越普遍，导致对有效治疗方案的需求增加。根据最近的健康统计数据，呼吸系统疾病占全球发病率和死亡率的相当大一部分，这需要像体外二氧化碳去除设备这样的创新解决方案。这个不断增长的患者群体可能会推动市场扩张，因为医疗服务提供者寻求实施先进技术以有效管理这些疾病。因此，随着对高效呼吸支持系统需求的增加，市场有望增长。

### 增加对医疗基础设施的投资

对医疗基础设施的投资是体外二氧化碳去除设备市场的关键驱动因素。随着各国优先改善医疗保健，先进医疗技术的资金投入显著增加。这种投资在重症监护病房中尤为明显，因为有效的呼吸支持需求至关重要。增强的基础设施使得将复杂设备，包括体外二氧化碳去除系统，整合到临床实践中成为可能。此外，公私合营伙伴关系正在出现，以促进这些技术的开发和分发。随着医疗系统的发展，市场预计将扩大，推动这一增长的是支持先进治疗选择的资源和设施的日益可用。

### 提高对体外技术的认识和培训

关于体外技术的意识和培训在医疗界日益受到重视，积极影响着体外二氧化碳去除设备市场。随着医疗专业人员对这些设备的好处和应用的了解加深，其采用率预计将上升。正在组织教育项目和研讨会，以提高与体外二氧化碳去除相关的技能和知识。这种临床医生的熟练程度不仅改善了患者护理，还鼓励医院投资于这些技术。市场可能会从这一趋势中受益，因为一支训练有素的劳动力对于先进医疗设备的成功实施至关重要。

### 体外二氧化碳去除设备的技术进步

体外二氧化碳去除设备市场正在经历技术进步的激增，这些进步提高了设备的效率和患者的治疗效果。诸如改进的膜技术和设备的小型化等创新使这些系统更加有效且用户友好。例如，人工智能在监测和控制二氧化碳水平中的集成变得越来越普遍。这不仅优化了性能，还降低了并发症的风险。此外，预计市场在未来五年内将以约12%的复合年增长率增长，这一增长受到这些进步的推动。随着医疗服务提供者寻求采用尖端解决方案，对复杂的体外二氧化碳去除设备的需求可能会增加，从而推动市场向前发展。

### 体外二氧化碳去除设备的监管支持

监管支持在塑造体外二氧化碳去除设备市场中发挥着至关重要的作用。各国政府和卫生当局越来越认识到这些设备在重症监护环境中的重要性。为了鼓励创新和采用，正在实施简化的审批流程和有利的报销政策。例如，最近的举措旨在加快新技术的审查，确保有效的解决方案更快地进入市场。这种监管环境不仅促进了竞争，还增强了患者获得先进治疗的机会。因此，预计市场将见证批准设备数量的稳步增加，进一步刺激该领域的增长和投资。

## Future Outlook

体外二氧化碳去除设备市场预计将在2024年至2035年间以10.29%的年均增长率增长，推动因素包括技术进步、呼吸系统疾病增加以及医疗支出上升。

**New opportunities:**

- 为家庭护理环境开发便携式二氧化碳去除设备。

到2035年，市场预计将会强劲，受到创新和需求增加的推动。

## Segment Insights

### 按技术：吸收技术（最大）与膜技术（增长最快）

在体外二氧化碳去除设备市场中，技术细分展示了多种二氧化碳去除方法。吸收技术目前占据最大的市场份额，主要由于其已建立的效率和在各个行业的广泛应用。紧随其后的是膜技术，正在迅速获得关注，并被认为是增长最快的细分市场，这得益于材料科学和工程的进步，提升了其性能和适用性。

技术：吸收（主导）与膜（新兴）

吸收技术作为市场的主导力量，利用液体吸收剂有效捕获二氧化碳。这种方法因其可靠性和效率而广受认可，成为许多应用中的首选，从工业过程到环境管理。相比之下，膜技术采用选择性透过膜将二氧化碳与其他气体分离，正逐渐成为一种有前景的替代方案。它提供了多个优势，如降低能耗和紧凑设计，使其成为小型模块化设置的吸引选项。随着研究不断完善膜材料，其采用有望加速，可能重塑市场格局。

### 按应用：医院使用（最大）与家庭护理（增长最快）

在体外二氧化碳去除设备市场中，应用领域多样，包括医院使用、居家护理、紧急医疗服务和运输。目前，医院使用占据了最大的市场份额，因为医院广泛采用先进的医疗技术。该细分市场受益于在手术和重症护理中需要二氧化碳去除的高患者治疗量，巩固了其在市场中的重要角色。

医院使用（主导）与居家护理（新兴）

医院使用细分市场仍然是体外二氧化碳去除设备市场的主导力量，其特点是依赖于先进的医疗系统和熟练的医疗专业人员。医院将这些设备整合到重症监护环境中，提高了手术和重症监护中的患者结果。相反，家庭护理细分市场正在迅速崛起，推动这一趋势的是对便携式和用户友好设备的需求，使患者能够在医疗设施外管理他们的病情。这一趋势受到技术进步和患者对改善生活质量的渴望的推动，同时也反映了对个性化医疗日益重视的趋势。

### 按设备类型：便携设备（最大）与固定设备（增长最快）

在体外二氧化碳去除设备市场中，便携式设备占据了最大的市场份额，这归因于它们在各种临床环境中的多功能性和易用性。这些设备因其可移动性而受到青睐，使医疗服务提供者能够轻松运输，从而在医院和门诊设施中促进了更广泛的采用。相比之下，固定设备吸引了相当大的市场兴趣，因为它们在重症监护室和康复中心等稳定环境中往往提供更高的效率和更好的性能。

便携设备（主导）与固定设备（新兴）

便携式设备已在体外二氧化碳去除设备市场中确立了主导地位，驱动因素是对灵活性和患者流动性的需求。它们被设计用于在紧急情况下快速部署，使其在急性护理场景中至关重要。与此同时，固定设备正在迅速崛起，因为医院正在寻找能够提供一致且高水平性能的设备。随着技术的进步，这些设备现在被设计为能够处理更大容量的二氧化碳去除，使其成为重症护理环境中长期治疗的有吸引力的选择。

### 按最终用途：临床环境（最大）与家庭医疗保健（增长最快）

在体外二氧化碳去除设备市场中，临床环境占据了最大的份额，主要是由于其对先进医疗技术在危重患者护理中的广泛依赖。医院和专科诊所利用这些设备来提高呼吸问题患者的治疗效果，从而主导了市场格局。相反，家庭医疗领域正在迅速获得关注。随着医疗服务向更个性化的选项转变，患者更倾向于在家中接受治疗，导致这些设备在家庭环境中的采用率增加。

临床环境（主导）与家庭医疗（新兴）

临床环境在体外二氧化碳去除设备市场中至关重要，展示了实施此类设备的强大基础设施，得到了受过培训的医疗专业人员和先进技术的支持。这些环境优先考虑效率、安全性和患者结果，从而巩固了其主导市场地位。另一方面，居家医疗代表了一个新兴领域，受到技术进步和消费者对居家治疗解决方案偏好的推动。随着不断创新旨在提高使用便利性和患者舒适度，该领域预计将经历指数级增长，以满足日益渴望在家中获得医疗服务的人群的需求。

## Regional Market Share Analysis

体外二氧化碳去除设备市场收入表现出强劲的区域多样性，反映出不同地区的增长动态。在2023年，北美以5.2亿美元的估值领先市场，预计到2032年将上升至12.5亿美元，展示了其在行业中的重要角色。欧洲紧随其后，2023年市场估值为3亿美元，预计将达到7.5亿美元，推动因素是先进呼吸设备的日益普及。

亚太地区虽然较小，但显示出从1.5亿美元到4亿美元的良好增长，突显出新兴经济体对医疗保健改善的日益关注。

南美和中东及非洲目前是最不具主导地位的地区，2023年的估值分别为5000万美元和200万美元；然而，它们暗示了其医疗保健系统发展的潜力。这些地区的市场增长受到医疗保健支出增加、技术进步和慢性呼吸疾病日益普遍的影响，为市场参与者提供了机会。体外二氧化碳去除设备市场细分显示出北美和欧洲的明显偏好，而亚太地区则显示出良好的增量增长。

## Competitive Benchmarking

体外二氧化碳去除设备市场正在经历重大变革，这些变革是由技术进步和临床环境中对有效二氧化碳管理日益增长的需求驱动的。该领域的公司专注于创新产品开发，提升现有解决方案，并在各种医疗场景中扩大应用，特别是在呼吸护理方面。市场上既有成熟的参与者，也有新兴的进入者，各自努力通过战略合作、技术进步和以客户为中心的方法来争夺市场份额。

竞争洞察显示，市场环境的特点是快速创新、激进的营销策略以及对合规性的高度关注，所有这些都旨在满足医疗服务提供者和患者的多样化需求。CO2 Solutions通过其旨在改善患者结果和满足临床需求的先进技术，在体外二氧化碳去除设备市场中占据了显著的地位。

该公司的优势在于其专有的二氧化碳去除技术，该技术在管理呼吸系统疾病患者的二氧化碳水平方面提供了高效和有效的解决方案。通过专注于研究和开发，CO2 Solutions建立了一个强大的产品组合，针对医疗界的特定需求，增强了其竞争优势。

与医疗机构的合作伙伴关系的重视增强了其市场存在感，使其设备在各种医疗环境中的可及性和整合性更强，从而巩固了其作为这一专业市场关键参与者的声誉。百特国际被认为是体外二氧化碳去除设备市场的重要竞争者，利用其在医疗行业的丰富经验和成熟基础设施。

该公司受益于广泛的覆盖面和多样化的产品，能够满足不同患者护理细分市场的需求，这使其在竞争中处于有效的竞争地位。百特的优势包括其强大的分销网络和对创新的承诺，使其能够迅速响应市场变化和客户需求。对高质量制造和严格遵守监管标准的关注进一步增强了百特在医疗服务提供者眼中的可信度和可靠性。

因此，百特国际继续扩大其在体外二氧化碳去除市场的影响力和足迹，强调其在全球范围内提供有效患者护理解决方案的角色。

## Recent News & Developments

最近在体外二氧化碳去除设备市场的发展突显出对创新技术和关键参与者之间战略合作的日益重视。像美敦力和百特国际这样的公司报告了其设备功能的进展，旨在改善患者的治疗效果。此外，Pulmonx公司由于其开创性的肺容积缩小技术而在市场份额上有所增加，这些技术有效地整合了二氧化碳去除设备。在并购方面，Getinge AB和Teleflex Incorporated等公司积极寻求战略联盟，以扩大其产品组合并改善市场覆盖率。

这种整合趋势反映了一个竞争激烈的市场，专注于整合先进技术以满足全球医疗需求的增长。

此外，随着医疗服务提供者对承诺改善患者护理和提高运营效率的设备的投资，市场估值显著提升。体外二氧化碳去除设备市场的整体前景依然积极，受到全球慢性呼吸疾病日益增加的紧迫需求的推动。

## Report Scope

| 2024年市场规模 | 1.261（十亿美元） |
| --- | --- |
| 2025年市场规模 | 1.391（十亿美元） |
| 2035年市场规模 | 3.705（十亿美元） |
| 复合年增长率（CAGR） | 10.29%（2024 - 2035） |
| 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 历史数据 | 2019 - 2024 |
| 市场预测单位 | 十亿美元 |
| 主要公司简介 | 市场分析进行中 |
| 覆盖的细分市场 | 市场细分分析进行中 |
| 主要市场机会 | 生物相容材料的进步提升了体外二氧化碳去除设备市场的性能。 |
| 主要市场动态 | 技术进步和监管变化推动了体外二氧化碳去除设备市场的创新和竞争。 |
| 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 |

## Frequently Asked Questions

**Q: 到2035年，体外CO2去除设备市场的预计市场估值是多少？**
A: 预计到2035年，市场将达到约37.05亿美元。

**Q: 2024年体外二氧化碳去除设备市场的市场估值是多少？**
A: 2024年的市场估值为12.61亿美元。

**Q: 在2025年至2035年的预测期内，体外CO2去除设备市场的预期CAGR是多少？**
A: 在此期间，市场的预期CAGR为10.29%。

**Q: 到2035年，预计哪个技术领域的估值最高？**
A: 膜技术和吸附技术领域预计到2035年各自将达到约11.34亿美元。

**Q: 体外二氧化碳去除设备的主要应用是什么？**
A: 主要应用包括医院使用、家庭护理、紧急医疗服务和运输。

**Q: 到2035年，预计哪种设备类型将主导市场？**
A: 预计到2035年，固定设备将占主导地位，预计估值为189.6亿美元。

**Q: 在体外二氧化碳去除设备市场中，主要参与者是谁？**
A: 主要参与者包括美敦力、费森尤斯医疗护理、百特国际和捷宁。

**Q: 到2035年，家庭护理应用领域的预期估值是多少？**
A: 到2035年，家庭护理应用领域预计将达到约9亿美元。

**Q: 到2035年，便携设备市场与固定设备市场相比如何？**
A: 到2035年，便携式设备预计将达到11.34亿美元，而固定设备预计将达到18.96亿美元。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/extracorporeal-co2-removal-device-market-37282*